Strong October for GenMark, Myriad Stocks Lead GWDN Index Rise

Overall, the Index gained 5 percent — less than the Nasdaq, which was up 6 percent for October, but outperforming the Nasdaq Biotech Index, which rose nearly 4 percent, and the Dow Jones Industrial Average, which gained 3 percent.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.